Immuno-Oncology (IO) development is booming across the 8MM*, with IO agents being investigated in most cancer types, in combination or alone, representing a huge commercial opportunity for established players and novel developers alike, says GlobalData, a leading data and analytics company. GlobalData’s latest report, ‘Immuno-oncology Development Trends and Opportunities’ combines research with a global, cross-specialty […]